Glyburide was associated with a lower risk of cardiovascular events (including congestive heart failure) than was rosiglitazone (P<0.05), and the risk associated with metformin was similar to that ...

Data Synthesis: Studies of glyburide and glipizide have found little or no transfer of these drugs across the placenta, whereas metformin and rosiglitazone cross readily.

The largest study to date of glyburide vs insulin for gestational diabetes identifies an increased risk of adverse neonatal outcomes with glyburide; however, insulin may not be best for all women.

The model was less sensitive to the one-time costs of inpatient treatment and patient education. CONCLUSION: Glyburide is less costly than insulin for the treatment of gestational diabetes.

An increased risk for cancer was found with longer cumulative durations and higher cumulative doses of glyburide, according to recent study findings published in Diabetes Care. &ldquo;The use of ...

(HealthDay News) — For patients with gestational diabetes mellitus (GDM), glyburide and metformin are comparable in terms of glucose control and safety, according to a study published in ...

Glyburide and metformin are active ingredients in several prescription-only medications indicated for the treatment of patients with type 2 diabetes. The FDA has issued an alert regarding the purchase ...

Maryland Heights, MO, SugarMDs, LLC is voluntarily recalling Lot: 22165-003 Advance Glucose Support Supplement in 60, 120 and 180 count bottles to the consumer level. FDA analysis has found the ...

--Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired the U.S. rights to ...